Maitonin Tablet 25 mg (Bethanechol Chloride)

Adult dose

Adults: Administer 10 ~ 25 milligrams per dose 3 ~ 4 times daily. Taking this medicine immediately after meals may cause symptoms such as nausea and vomiting; therefore, taking it on an empty stomach is recommended.

This medication should be administered subcutaneously with atropine sulfate to alleviate symptoms if serious side effects occur after use. This medication should not be used in patients with mechanical obstruction in the gastrointestinal tract or urinary tract. It should also be avoided by patients with spastic gastrointestinal diseases, gastric ulcers, or acute inflammatory gastrointestinal diseases. Patients with peritonitis, vagus nerve hypertonicity, and asthma should not use this medication. Patients with excessive thyroid function and those with coronary artery obstruction should also refrain from taking this medication. Care is required for patients with bradycardia or conductive heart disorders, vasomotor instability, and those with hypotension or hypertension. Patients with myocardial infarction or severe heart disease should avoid this medication. Patients with epilepsy or Parkinson's disease, as well as those undergoing anticholinesterase treatment should not use this medication, and those with unhealed wounds after gastrointestinal surgery should also refrain from taking it. Pregnant women should not take this medication, and patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should also avoid it due to the presence of lactose in this medication. This medication contains Yellow No. 4 as a dye, so it should be used with caution by individuals who have allergies or hypersensitivity to this component. Side effects may occasionally include gastrointestinal symptoms such as heartburn, abdominal discomfort, nausea, vomiting, gastric cramps, and diarrhea. Additionally, sweating, flushing, and increased salivation may occur. Cardiac side effects could include rapid heart rate or decreased blood pressure, and in patients with hypertension, transient atrial fibrillation may occur. In the event of overdose, serious symptoms such as fainting due to cardiac arrest, complete heart block, respiratory distress, orthostatic hypotension, involuntary bowel evacuation, and sudden urge to urinate may appear. Additionally, asthma patients may experience asthma attacks, along with symptoms like chest tightness, headaches, and discomfort. This medication may interfere with the effects of quinidine and procainamide, so caution is necessary when used together. Furthermore, the effects may be enhanced when combined with cholinergic drugs, especially anticholinesterase inhibitors, so caution is advised. Patients taking sympatholytic agents who use this medication may experience severe abdominal symptoms and sudden drops in blood pressure, necessitating special attention.

• heartburn
• abdominal discomfort
• nausea
• vomiting
• stomach cramps
• diarrhea
• sweating
• flushing
• salivation
• palpitations

This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best to avoid storing the medication in extremely hot or cold environments and to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance

Yellow round tablet

Package unit

100 tablets (10 tablets/PTPX10), 100 tablets/bottle, 300 tablets/bottle